Back to Agenda
Session 1: Manufacturing and Supply – Ensuring Patients’ Access
Session Chair(s)
Yvonne Stewart, PHD
Head of Brexit Implementation, Office of the CEO and CFO, GSK, United Kingdom
Speaker(s)
Elizabeth Kuiper, MA
Executive Director, Public Affairs, European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium
Industry Case Example: Putting Brexit Supply Impact in a Global Perspective
Gerald W. Heddell
Director, Inspection Enforcement & Standards Division , Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
UK Third Country Scenario Implications on Supply
Paul Sexton
GMP Manager, Health Products Regulatory Authority (HPRA), Ireland
A National Member State’s Perspective
Have an account?
